Understand, but what I'm referring to is the new OTC Market
Understand, but what I'm referring to is the new OTC Market listing of OTCID, if any company isn't able to meet the new standards OTC has set, then the company will remain in Pink Limited or Expert Market, which I believe will hurt the PPS.
My opinion of why the whole new OTCID came about, was to build institutional financing for truly legitimate OTC-traded companies.
A lot of small-cap companies are migrating to OTC Markets. because of Nasdaq and NYSE tighten listing requirements
OTC Market is looking to capitalize by forming the new listing.
Now it is up to the CEO's of the pink companies to capitalize and grow out of the OTC Market.
My thoughts are a lot want make it at the very start, but could come on in the near future.
4
Univec Conglomerate Inc (UNVC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
MINISO Group's Strategic Move with Black Myth: Wukong Shares of MINISO Group Holding Ltd (HK: 9896) have recently made headlines, experiencing a notable spike in value. This upward trend follows their announcement about a partnership with the renowned video game 'Black Myth: Wukong'. This collaboration marks a significant moment for MINISO, as they aim to delve deeper...
Continue Reading
Sentry's Commitment to Maui Nonprofits Sentry is stepping up with a remarkable $1 million donation aimed at supporting three key nonprofit organizations in Maui. This generous contribution highlights their dedication to fostering community well-being, environmental restoration, and aiding in the ongoing recovery of the island. Beneficiaries of the Donation The Sentry...
Continue Reading
VersaBank Reports Strong Financial Performance in Q3 VersaBank has demonstrated impressive results in its fiscal 2024 third quarter, highlighting the strength of its business model. As a prominent digital bank in North America, VersaBank has made significant progress, particularly with its recent foray into the US market. Key Financial Highlights For the nine-month period...
Continue Reading
Microbot Medical Secures Funding for Future Developments Microbot Medical Inc. (NASDAQ: MBOT), a pioneering med-tech enterprise, has successfully raised approximately $11.8 million in gross proceeds through its recent funding initiatives. This impressive capital injection stems from a registered direct offering of 4,000,001 shares of common stock, priced at $1.75 each,...
Continue Reading
Transforming Enterprises with AI Agents Infosys, a leader in next-generation digital services and consulting, has unveiled over 200 enterprise AI agents that revolutionize how businesses operate. These AI agents, part of the Infosys Topaz™ AI offerings and collaborating with Google Cloud, are tailored to deliver measurable benefits by transforming intricate workflows...
Continue Reading
